MedPath

Perceived Health After Hospitalization for COVID-19

Completed
Conditions
COVID-19, Post-hospitalization, Disease Impact
Interventions
Other: Questionnaires
Registration Number
NCT04912804
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

There are currently no precise data available on the impact of COVID-19 on the daily life of patients after hospitalization. For the moment, studies have only demonstrated a strong impact of the diagnosis on the domains of quality of life explored by the MOS-SF36 questionnaire and the PHQ-9 depression score. Concerning the impact of COVID-19 disease after conventional hospitalization, field reports indicate extremely intense fatigue and a major physical impact lasting several weeks

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
207
Inclusion Criteria
  • Adult patient
  • Patient with a diagnosis of COVID-19 confirmed by PCR and/or CT scan
  • Patient hospitalized in a short stay unit (excluding intensive care and rehabilitation) for a COVID-19 infection
  • Patient providing oral consent to participate in the study
  • Patient able to understand and answer the questionnaires used
  • Patient able to answer the questions on an electronic device and to receive requests by email and/or SMS
  • Patient who has electronic equipment at home and an Internet subscription allowing him/her to answer the questionnaires online
Exclusion Criteria
  • Patient under guardianship, curatorship or a measure of judicial safeguard

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
COVID-19 PatientQuestionnairesPatient discharged from a conventional short-stay hospitalization unit.
Primary Outcome Measures
NameTimeMethod
The value of perceived health scores in patients who achieved PASS and MCIIThrough study completion, an average of 6 months
Time to PASS and CID in patients discharged from conventional hospitalization for COVID-19 diseaseThrough study completion, an average of 6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Dijon Bourogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath